NervGen Pharma Market Cap

NervGen Pharma has a market cap or net worth of CAD 218.52 million as of August 14, 2025. Its market cap has increased by 11.20% in one year.

Market Cap

218.52M

Enterprise Value

204.13M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

2.98

Market Cap Chart

Since March 15, 2019, NervGen Pharma's market cap has increased from 50.07M to 218.52M, an increase of 336.41%. That is a compound annual growth rate of 25.80%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	218.52M	-1.02%
Dec 31, 2024	220.77M	37.18%
Dec 29, 2023	160.94M	71.42%
Dec 30, 2022	93.89M	-24.19%
Dec 31, 2021	123.84M	58.14%
Dec 31, 2020	78.31M	36.12%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Curaleaf Holdings	3.23B
Green Thumb Industries	2.83B
Trulieve Cannabis	2.38B
Sienna Senior Living	1.69B
dentalcorp Holdings	1.61B
Cronos Group	1.39B
WELL Health Technologies	1.27B
Extendicare	1.13B

Market Cap Rankings